New cancer clinical trial: A Phase II Study of Trastuzumab Deruxtecan (T-DXd) Plus Pyrotinib in HER2-Positive Advanced Breast Cancer After Progression on T-DXd

Published on: 2026-09-23T04:00:00Z
Conditions: Breast Cancer
Interventions: Drug: Trastuzumab Deruxtecan (T-DXd); Drug: Pyrotinib
Sponsors: Fujian Medical University
Not yet recruiting
https://ift.tt/c7jAhwq A Phase II Study of Trastuzumab Deruxtecan (T-DXd) Plus Pyrotinib in HER2-Positive Advanced Breast Cancer After Progression on T-DXd